Rodger Novak

Insider Reports History

Entity
Individual
Location
C/O Crispr Therapeutics Ag, 200 Sidney Street, Cambridge, MA
Signature
/s/ Michael Esposito, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rodger Novak:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG President, Director Common Shares 573K $35.8M $62.50 Jun 30, 2021 Direct

Insider Reports Filed by Rodger Novak

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG Jun 30, 2021 1 -$4.13M 4 Jul 1, 2021 President, Director
CRSP CRISPR Therapeutics AG Jun 28, 2021 1 -$3.91M 4 Jun 30, 2021 President, Director
CRSP CRISPR Therapeutics AG Jun 21, 2021 6 -$3.22M 4 Jun 23, 2021 President, Director